Maggio 9, 2026

comunicati

Paradigm Therapeutics Acquires Late Stage “Breakthrough Therapy” Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB)

(Adnkronos) - 'Topical Therapy for Treating the Wounds and Lesions on the Entire Skin Surface' MT PLEASANT, S.C., Aug. 22, 2023...

Paradigm Therapeutics acquisisce la “terapia rivoluzionaria” in fase avanzata per il trattamento di tutti i sottotipi di Epidermolysis Bullosa (EB)

(Adnkronos) - "Terapia topica per il trattamento di ferite e lesioni sull'intera superficie cutanea"  MT PLEASANT, S.C., 22 agosto 2023 /PRNewswire/...

COP28 announces innovative thematic program to progress action on its goals across Just Energy Transition, Finance, Health, Lives & Livelihoods and Inclusivity

(Adnkronos) - ABU DHABI, UAE, Aug. 22, 2023 /PRNewswire/ -- The COP28 UAE Presidency has announced an ambitious and inclusive...

Novavax’s Updated Protein-based XBB COVID Vaccine Induced Neutralizing Responses Against Emerging Subvariants, Including EG.5.1 and XBB.1.16.6

(Adnkronos) - GAITHERSBURG, Md., Aug. 22, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with...